A detailed history of Private Advisor Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 276,159 shares of ABBV stock, worth $56.2 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
276,159
Previous 280,551 1.57%
Holding current value
$56.2 Million
Previous $48.1 Million 13.33%
% of portfolio
0.35%
Previous 0.32%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$163.84 - $199.33 $719,585 - $875,457
-4,392 Reduced 1.57%
276,159 $54.5 Million
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $3.85 Million - $4.5 Million
24,896 Added 9.74%
280,551 $48.1 Million
Q1 2024

Apr 30, 2024

SELL
$159.82 - $182.1 $902,823 - $1.03 Million
-5,649 Reduced 2.16%
255,655 $46.6 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $12,796 - $14,412
-93 Reduced 0.04%
261,304 $40.5 Million
Q3 2023

Nov 02, 2023

SELL
$133.59 - $154.65 $884,766 - $1.02 Million
-6,623 Reduced 2.47%
261,397 $39 Million
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $873,240 - $1.09 Million
-6,590 Reduced 2.4%
268,020 $36.1 Million
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $3.14 Million - $3.62 Million
-21,720 Reduced 7.33%
274,610 $43.8 Million
Q4 2022

Jan 18, 2023

SELL
$138.31 - $165.87 $1.58 Million - $1.89 Million
-11,404 Reduced 3.71%
296,330 $0
Q3 2022

Oct 14, 2022

SELL
$134.21 - $153.93 $11 Million - $12.6 Million
-81,871 Reduced 21.01%
307,734 $41.3 Million
Q2 2022

Jul 13, 2022

SELL
$137.62 - $174.96 $6.07 Million - $7.72 Million
-44,140 Reduced 10.18%
389,605 $59.7 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $4.01 Million - $4.97 Million
30,356 Added 7.53%
433,745 $70.3 Million
Q4 2021

Feb 10, 2022

SELL
$107.43 - $135.93 $16.4 Million - $20.8 Million
-153,113 Reduced 27.51%
403,389 $54.6 Million
Q3 2021

Oct 14, 2021

BUY
$106.4 - $120.78 $17.3 Million - $19.6 Million
162,314 Added 41.18%
556,502 $60 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $3.36 Million - $3.74 Million
31,949 Added 8.82%
394,188 $44.4 Million
Q1 2021

Apr 22, 2021

BUY
$102.3 - $112.62 $8.25 Million - $9.08 Million
80,606 Added 28.62%
362,239 $39.2 Million
Q4 2020

Apr 01, 2021

BUY
$80.49 - $108.67 $4.6 Million - $6.21 Million
57,142 Added 25.45%
281,633 $30.2 Million
Q3 2020

Nov 02, 2020

BUY
$85.91 - $100.83 $27,577 - $32,366
321 Added 0.14%
224,491 $20 Million
Q2 2020

Aug 17, 2020

BUY
$73.37 - $98.18 $2.16 Million - $2.9 Million
29,503 Added 15.16%
224,170 $22 Million
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $991,300 - $1.5 Million
15,369 Added 8.57%
194,667 $14.8 Million
Q4 2019

Feb 10, 2020

BUY
$72.13 - $90.25 $1.36 Million - $1.7 Million
18,857 Added 11.75%
179,298 $15.9 Million
Q3 2019

Nov 13, 2019

BUY
$62.98 - $75.72 $1.88 Million - $2.26 Million
29,856 Added 22.86%
160,441 $12.2 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $804,299 - $1.03 Million
-12,242 Reduced 8.57%
130,585 $9.5 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $231 - $272
-3 Reduced -0.0%
142,827 $11.5 Million
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $496,215 - $611,967
-6,374 Reduced 4.27%
142,830 $13.2 Million
Q3 2018

Nov 01, 2018

SELL
$88.91 - $98.84 $1.11 Million - $1.23 Million
-12,446 Reduced 7.7%
149,204 $14.1 Million
Q2 2018

Aug 09, 2018

BUY
$89.78 - $106.23 $6.05 Million - $7.15 Million
67,347 Added 71.42%
161,650 $15 Million
Q1 2018

May 09, 2018

BUY
$92.01 - $123.21 $222,388 - $297,798
2,417 Added 2.63%
94,303 $8.93 Million
Q4 2017

Feb 07, 2018

SELL
$89.56 - $98.21 $6.01 Million - $6.59 Million
-67,101 Reduced 42.21%
91,886 $9.12 Million
Q3 2017

Nov 13, 2017

SELL
$69.85 - $89.22 $321,938 - $411,214
-4,609 Reduced 2.82%
158,987 $14.4 Million
Q2 2017

Aug 10, 2017

BUY
N/A
163,596
163,596 $11.8 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.